Cargando…
P68. A new EGFR - EpCAM bispecific antibody enhances the efficacy of adoptive T-cell therapy in a murine gastric tumour model
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4072107/ http://dx.doi.org/10.1186/2051-1426-2-S2-P42 |
_version_ | 1782322905662619648 |
---|---|
author | Kobold, S Steffen, J Grassmann, S Castoldi, R Schmollinger, J Sustmann, C Nierderfellner, G Klein, C Bourquin, C Endres, S |
author_facet | Kobold, S Steffen, J Grassmann, S Castoldi, R Schmollinger, J Sustmann, C Nierderfellner, G Klein, C Bourquin, C Endres, S |
author_sort | Kobold, S |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-4072107 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-40721072014-06-27 P68. A new EGFR - EpCAM bispecific antibody enhances the efficacy of adoptive T-cell therapy in a murine gastric tumour model Kobold, S Steffen, J Grassmann, S Castoldi, R Schmollinger, J Sustmann, C Nierderfellner, G Klein, C Bourquin, C Endres, S J Immunother Cancer Poster Presentation BioMed Central 2014-03-12 /pmc/articles/PMC4072107/ http://dx.doi.org/10.1186/2051-1426-2-S2-P42 Text en Copyright © 2014 Kobold et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Poster Presentation Kobold, S Steffen, J Grassmann, S Castoldi, R Schmollinger, J Sustmann, C Nierderfellner, G Klein, C Bourquin, C Endres, S P68. A new EGFR - EpCAM bispecific antibody enhances the efficacy of adoptive T-cell therapy in a murine gastric tumour model |
title | P68. A new EGFR - EpCAM bispecific antibody enhances the efficacy of adoptive T-cell therapy in a murine gastric tumour model |
title_full | P68. A new EGFR - EpCAM bispecific antibody enhances the efficacy of adoptive T-cell therapy in a murine gastric tumour model |
title_fullStr | P68. A new EGFR - EpCAM bispecific antibody enhances the efficacy of adoptive T-cell therapy in a murine gastric tumour model |
title_full_unstemmed | P68. A new EGFR - EpCAM bispecific antibody enhances the efficacy of adoptive T-cell therapy in a murine gastric tumour model |
title_short | P68. A new EGFR - EpCAM bispecific antibody enhances the efficacy of adoptive T-cell therapy in a murine gastric tumour model |
title_sort | p68. a new egfr - epcam bispecific antibody enhances the efficacy of adoptive t-cell therapy in a murine gastric tumour model |
topic | Poster Presentation |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4072107/ http://dx.doi.org/10.1186/2051-1426-2-S2-P42 |
work_keys_str_mv | AT kobolds p68anewegfrepcambispecificantibodyenhancestheefficacyofadoptivetcelltherapyinamurinegastrictumourmodel AT steffenj p68anewegfrepcambispecificantibodyenhancestheefficacyofadoptivetcelltherapyinamurinegastrictumourmodel AT grassmanns p68anewegfrepcambispecificantibodyenhancestheefficacyofadoptivetcelltherapyinamurinegastrictumourmodel AT castoldir p68anewegfrepcambispecificantibodyenhancestheefficacyofadoptivetcelltherapyinamurinegastrictumourmodel AT schmollingerj p68anewegfrepcambispecificantibodyenhancestheefficacyofadoptivetcelltherapyinamurinegastrictumourmodel AT sustmannc p68anewegfrepcambispecificantibodyenhancestheefficacyofadoptivetcelltherapyinamurinegastrictumourmodel AT nierderfellnerg p68anewegfrepcambispecificantibodyenhancestheefficacyofadoptivetcelltherapyinamurinegastrictumourmodel AT kleinc p68anewegfrepcambispecificantibodyenhancestheefficacyofadoptivetcelltherapyinamurinegastrictumourmodel AT bourquinc p68anewegfrepcambispecificantibodyenhancestheefficacyofadoptivetcelltherapyinamurinegastrictumourmodel AT endress p68anewegfrepcambispecificantibodyenhancestheefficacyofadoptivetcelltherapyinamurinegastrictumourmodel |